Chronic mountain sickness

Winslow, R. M., and C. C. Monge (1987). Hypoxia, Polycythemia and Chronic Mountain Sickness. Baltimore Johns Hopkins University Press. Zapol, W.M., G.C. Liggins, R.C. Schneider, J. Qvist, M.T. Snider, R.K. Creasy, and P.W. Hochachka (1979). Regional blood flow during simulated diving in the conscious Weddell seal. J. Appl. Physiol. 47 968-973. [Pg.185]

Winslow, R.M., and C. Monge (1987). Hypoxia, Polycythemia, and Chronic Mountain Sickness. Baltimore Johns Hopkins University Press. [Pg.216]

In human populations, it is estimated that 10-15% of young and more than 30% of aged (above 50 years) high-altitude permanent residents (>2500 m) are at risk to develop chronic mountain sickness (47,48). Some of the major features of chronic mountain sickness are chronic alveolar hypoventilation associated with low... [Pg.472]

Monge-C C, Arregui A, Leon-Velarde F. Pathophysiology and epidemiology of chronic mountain sickness. Int J Sports Med 1992 13 S79-S81. [Pg.482]

Leon-Velarde F, Arregui A, Monge-C C, Ruiz Y, Ruiz H. Aging at high altitudes and the risk of Chronic Mountain Sickness. J Wild Med 1993 4 183-188. [Pg.483]

Ou LC, Sardella GL, Leiter JC, Brinck-Johnsen, Smith RP. Role of sex hormones in the development of chronic mountain sickness in rats. J Appl Physiol 1994 77 427-... [Pg.483]

Chronic Mountain Sickness This disease affects long-term inhabitants of high altitudes. Symp-... [Pg.338]

Hypertension Mountain sickness, acute Nephrotic syndrome Renal failure chronic acute, oliguric... [Pg.461]

Carbonic anhydrase inhibitors are used to decrease intraocular pressure in patients with open-angle (chronic) glaucoma and are not used in narrow-angle or acute glaucoma. Other uses include inducing diuresis, management of epilepsy, and treatment of high-altitude or acute mountain sickness. [Pg.387]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...